Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Ketofol as induction agent in diabetic patients.

View through CrossRef
Objective: To evaluate the role of ketofol as induction agent in diabetic patients. Study Design: Randomized Control Trial. Setting: Department of Anesthesia, Abwa Medical College, Faisalabad. Period: 01-12-21 to 01-05-22. Material & Methods: Patients after informed consent divided randomly into two groups 25 in each. Group A receiving propofol 1.5 mg/kg and Group B receiving ketofol 1:2 as induction agent. The dose given was 1ml for every 5Kg. Standard 5 parameter monitoring with pulse oximetry, ECG, non invasive BP done starting from preoperative to 2 minutes, 5 minutes and 10 minutes after induction agent given. MAP and HR were monitored. Hemodynamic instability was defined as I) Heart rate >160/min or <50/min. II) MAP>120mmHg or <60 mm Hg. Results: Total 50 patients included in this study. 25 in each group. The results show significant stability in hemodynamics in group B. Conclusion: Ketofol has better hemodynamic stability as induction agent in diabetic patients when used in a 2:1 ratio. This makes it a good choice for this specific patient population.
Title: Ketofol as induction agent in diabetic patients.
Description:
Objective: To evaluate the role of ketofol as induction agent in diabetic patients.
Study Design: Randomized Control Trial.
 Setting: Department of Anesthesia, Abwa Medical College, Faisalabad.
Period: 01-12-21 to 01-05-22.
Material & Methods: Patients after informed consent divided randomly into two groups 25 in each.
Group A receiving propofol 1.
5 mg/kg and Group B receiving ketofol 1:2 as induction agent.
 The dose given was 1ml for every 5Kg.
Standard 5 parameter monitoring with pulse oximetry, ECG, non invasive BP done starting from preoperative to 2 minutes, 5 minutes and 10 minutes after induction agent given.
MAP and HR were monitored.
Hemodynamic instability was defined as I) Heart rate >160/min or <50/min.
II) MAP>120mmHg or <60 mm Hg.
Results: Total 50 patients included in this study.
25 in each group.
The results show significant stability in hemodynamics in group B.
Conclusion: Ketofol has better hemodynamic stability as induction agent in diabetic patients when used in a 2:1 ratio.
This makes it a good choice for this specific patient population.

Related Results

Renal biopsy in diabetic patients: Histopathological and clinical correlations
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. A kidney biopsy in a diabetic patient must be considered when non-diab...
Clinical Knowledge and Practice of “Ketofol” at University of Gondar Comprehensive Specialized Hospital
Clinical Knowledge and Practice of “Ketofol” at University of Gondar Comprehensive Specialized Hospital
Background: Ketamine and propofol in a single syringe are reported to create an admixture used for balancing cardiorespiratory effects during induction of general anesthesia. This ...
GW24-e3068 The risk factors analysis and follow-up study of prehypertensive diabetic patients
GW24-e3068 The risk factors analysis and follow-up study of prehypertensive diabetic patients
Objectives To analyse the prevalence and risk factors of prehypertension among normal blood pressure diabetic patients. To assess the renal function of prehyperte...
Diabetic Foot in Qatar: A Primary Care Perspective
Diabetic Foot in Qatar: A Primary Care Perspective
Diabetic Foot in QatarA primary care Perspective Introduction Diabetes represents a major public health burden in developing countries, especially the Arabian Gulf region, which is...
Comparative Analysis of Hepatocellular Carcinoma Patients with and Without Type 2 Diabetes Mellitus
Comparative Analysis of Hepatocellular Carcinoma Patients with and Without Type 2 Diabetes Mellitus
Purpose of the Study: To evaluate the clinical impact of Type 2 Diabetes Mellitus (T2DM) in patients with Hepatocellular Carcinoma (HCC) in comparison to those without T2DM. Metho...

Back to Top